Try our Advanced Search for more refined results

Anacor Pharmaceuticals, Inc. v. Lupin Limited et al

  1. September 27, 2021

    FlatWing Won't Get $690K Atty Fees In Pfizer Unit Patent Fight

    A Delaware federal judge on Monday denied a bid by two firms representing FlatWing Pharmaceuticals LLC to have Pfizer unit Anacor Pharmaceuticals Inc. reimburse roughly $690,000 in attorney fees that FlatWing incurred in patent litigation.

  2. June 24, 2021

    FlatWing Denied Atty Fees In Patent Fight With Pfizer Unit

    A federal magistrate judge has recommended against shifting nearly $690,000 in fees and expenses to Pfizer unit Anacor Pharmaceuticals from a company that challenged Anacor's patent for a toenail fungus treatment, citing an absence of evidence that Anacor pursued unreasonable infringement claims or patent defenses.

  3. June 17, 2021

    IP Forecast: Pro Wrestler Preps For Video Game Trial

    Professional wrestler Booker T is scheduled to take the stand next week before a Texas federal jury in a case alleging that video game giant Activision ripped off his military-themed persona to create a Call of Duty character. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.